Walleye Trading LLC 89bio, Inc. Call Options Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$6.66 - $16.03 $7,992 - $19,236	-1,200 Reduced 2.24%	52,300 $584,000
Q3 2023 Nov 14, 2023	BUY	$15.06 - $19.41 $760,530 - $980,205	50,500 Added 1683.33%	53,500 $826,000
Q2 2023 Aug 14, 2023	BUY	$14.15 - $22.03 $42,450 - $66,090	3,000 New	3,000 $56,000
Q4 2022 Feb 14, 2023	BUY	$5.52 - $12.73 $50,231 - $115,843	9,100 New	9,100 $115,000

158

108M

73.6K

1.19M

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $387M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.